Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main Class | Sub Class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMFA04000091 | Resolvin T1 | 7,13,20-Trihydroxy-8E,10Z,14E,16Z,18E-docosapentaenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04000092 | Resolvin T2 | 7,8,13-Trihydroxy-9E,11E,13E,15Z,19Z-docosapentaenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04000093 | Resolvin T3 | 7,12,13-Trihydroxy-8Z,10E,14E,16Z,19Z-docosapentaenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010049 | 10,13-diepi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010048 | 10,13-diepi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010117 | 10,17-diepi-17-F4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010116 | 10,17-diepi-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010047 | 10-epi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010050 | 10-epi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010121 | 10-epi-17-F4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010120 | 10-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010041 | 10-epi-7-F4c-NeuroP | (S,4Z,8E)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010040 | 10-epi-7-F4t-NeuroP | (S,4Z,8E)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010055 | 10-F4c-NeuroP | (S,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010005 | 10-F4-NeuroP | (4Z,7Z,11E)-12-(3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010058 | 10-F4t-NeuroP | (S,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010063 | 11-epi-11-F4c-NeuroP | 3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010066 | 11-epi-11-F4t-NeuroP | 3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010071 | 11-F4c-NeuroP | 3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010006 | 11-F4-NeuroP | 3-(3,5-dihydroxy-2-((1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010074 | 11-F4t-NeuroP | 3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010081 | 13,16-diepi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010080 | 13,16-diepi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010133 | 13,20-diepi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010132 | 13,20-diepi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010057 | 13-epi-10-F4c-NeuroP | (S,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010056 | 13-epi-10-F4t-NeuroP | (S,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010079 | 13-epi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010082 | 13-epi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010137 | 13-epi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010136 | 13-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010087 | 13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010003 | 13-F4-NeuroP | (4Z,7Z,10Z,14E)-15-(2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010090 | 13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010099 | 14-epi-14-F4c-NeuroP | (Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010102 | 14-epi-14-F4t-NeuroP | (Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010103 | 14-F4c-NeuroP | (Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010004 | 14-F4-NeuroP | (Z)-6-(3,5-dihydroxy-2-((1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010106 | 14-F4t-NeuroP | (Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010089 | 16-epi-13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010088 | 16-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010115 | 17-epi-17-F4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010118 | 17-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010119 | 17-F4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010002 | 17-F4-NeuroP | (4Z,7Z)-9-(3,5-dihydroxy-2-((1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010122 | 17-F4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010131 | 20-epi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010134 | 20-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010135 | 20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010001 | 20-F4-NeuroP | (4Z,7Z,10Z)-12-(3,5-dihydroxy-2-((E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010138 | 20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010065 | 4,11-diepi-11-F4c-NeuroP | 3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010064 | 4,11-diepi-11-F4t-NeuroP | 3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010017 | 4,7-diepi-4-F4c-NeuroP | (R,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010016 | 4,7-diepi-4-F4t-NeuroP | (R,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010073 | 4-epi-11-F4c-NeuroP | 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010072 | 4-epi-11-F4t-NeuroP | 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010015 | 4-epi-4-F4c-NeuroP | (R,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010018 | 4-epi-4-F4t-NeuroP | (R,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010023 | 4-F4c-NeuroP | (S,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010008 | 4-F4-NeuroP | (E)-6-(3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010026 | 4-F4t-NeuroP | (S,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010033 | 7,10-diepi-7-F4c-NeuroP | (R,4Z,8E)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010032 | 7,10-diepi-7-F4t-NeuroP | (R,4Z,8E)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010101 | 7,14-diepi-14-F4c-NeuroP | (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010100 | 7,14-diepi-14-F4t-NeuroP | (Z)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010105 | 7-epi-14-F4c-NeuroP | (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010010 | 7-epi-14-F4t-NeuroP | 8S,10R,14S-trihydroxy-4Z,12E,16Z,19Z-neuroprostatetraenoic acid-cyclo[7R,11R] | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010025 | 7-epi-4-F4c-NeuroP | (S,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010024 | 7-epi-4-F4t-NeuroP | (S,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010031 | 7-epi-7-F4c-NeuroP | (R,4Z,8E)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010034 | 7-epi-7-F4t-NeuroP | (R,4Z,8E)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010039 | 7-F4c-NeuroP | (S,4Z,8E)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010007 | 7-F4-NeuroP | (4Z,8E)-9-(3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010042 | 7-F4t-NeuroP | (S,4Z,8E)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010052 | ent-10,13-diepi-4-Fc-NeuroP | (S,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010053 | ent-10,13-diepi-4-Ft-NeuroP | (S,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010112 | ent-10,17-diepi-17-F4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010113 | ent-10,17-diepi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010108 | ent-10-epi-17-F4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010109 | ent-10-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010054 | ent-10-epi-4-Fc-NeuroP | (S,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010051 | ent-10-epi-4-Ft-NeuroP | (S,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010028 | ent-10-epi-7-F4c-NeuroP | (R,4Z,8E)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010029 | ent-10-epi-7-F4t-NeuroP | (R,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010046 | ent-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010043 | ent-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010070 | ent-11-epi-4-Fc-NeuroP | 3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010067 | ent-11-epi-4-Ft-NeuroP | 3-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010062 | ent-11-F4c-NeuroP | 3-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010059 | ent-11-F4t-NeuroP | 3-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010084 | ent-13,16-diepi-13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010085 | ent-13,16-diepi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010128 | ent-13,20-diepi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010129 | ent-13,20-diepi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010044 | ent-13-epi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010045 | ent-13-epi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010083 | ent-13-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010086 | ent-13-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010124 | ent-13-epi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010125 | ent-13-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010078 | ent-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010075 | ent-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010095 | ent-14-epi-14-F4t-NeuroP | (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010098 | ent-14-epi-14-F4t-NeuroP | (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010094 | ent-14-F4c-NeuroP | (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010091 | ent-14-F4t-NeuroP | (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010076 | ent-16-epi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010077 | ent-16-epi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010114 | ent-17-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010111 | ent-17-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010110 | ent-17-F4c-NeuroP | (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010107 | ent-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010127 | ent-20-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010130 | ent-20-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010126 | ent-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010123 | ent-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010068 | ent-4,11-diepi-4-Fc-NeuroP | 3-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010069 | ent-4,11-diepi-4-Ft-NeuroP | 3-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010020 | ent-4,7-diepi-4-Fc-NeuroP | (S,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010021 | ent-4,7-diepi-4-Ft-NeuroP | (S,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010060 | ent-4-epi-11-F4c-NeuroP | 3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010061 | ent-4-epi-11-F4t-NeuroP | 3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010022 | ent-4-epi-4-Fc-NeuroP | (S,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010019 | ent-4-epi-4-Ft-NeuroP | (S,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010014 | ent-4-F4c-NeuroP | (R,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010011 | ent-4-F4t-NeuroP | (R,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010036 | ent-7,10-diepi-4-Fc-NeuroP | (S,4Z,8E)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010037 | ent-7,10-diepi-4-Ft-NeuroP | (S,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010096 | ent-7,14-diepi-14-F4c-NeuroP | (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010097 | ent-7,14-diepi-14-F4t-NeuroP | (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010092 | ent-7-epi-14-F4c-NeuroP | (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010093 | ent-7-epi-14-F4t-NeuroP | (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010012 | ent-7-epi-4-F4c-NeuroP | (R,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010013 | ent-7-epi-4-F4t-NeuroP | (R,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010038 | ent-7-epi-4-Fc-NeuroP | (S,4Z,8E)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010035 | ent-7-epi-4-Ft-NeuroP | (S,4Z,8E)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010030 | ent-7-F4c-NeuroP | (R,4Z,8E)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
| LMFA04010027 | ent-7-F4t-NeuroP | (R,4Z,8E)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | Docosanoids [FA04] | - | 378.24 | C22H34O5 |
Download LMSD record summary for FA 22:5;O3